Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Neurology|September 13, 2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With DimethylfumarateMaria C Buscarinu, Francesca Gargano, Luana Lionetto, et al.
Cancers|July 26, 2020
Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA AnalysisAlessandro Ottaiano, Nicola Normanno, Sergio Facchini, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2026
Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancerSavino Cilla, Francesco Deodato, Donato Pezzulla, et al.
Clinical Colorectal Cancer|July 8, 2020
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER TrialMaria Carmela Piccirillo, Antonio Avallone, Chiara Carlomagno, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2023
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional studySavino Cilla, Maura Campitelli, Maria Antonietta Gambacorta, et al.
Neurology|May 26, 2026
Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap SyndromeAntonio Lauletta, Elena Rossini, Francesca Beretta, et al.
Oncotarget|February 18, 2017
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter surveyMassimiliano Berretta, Chiara Della Pepa, Paolo Tralongo, et al.
JAMA Network Open|July 26, 2021
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical TrialAntonio Avallone, Maria C Piccirillo, Guglielmo Nasti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2024
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: The IMPROVE TrialAntonio Avallone, Francesco Giuliani, Alfonso De Stefano, et al.
Pageof 9